Dr. Aaronson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
40 E 94th St Apt 23b
New York, NY 10128Phone+1 212-659-5400Fax+1 212-987-2240
Education & Training
- University of California San Francisco School of MedicineClass of 1966
Certifications & Licensure
- CA State Medical License 1967 - Present
- NY State Medical License 1971 - 2026
- VA State Medical License 1971 - 2020
- DC State Medical License 1974 - 1982
Publications & Presentations
PubMed
- 130 citationsApoptotic cell death in disease-Current understanding of the NCCD 2023.Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A Aaronson, John M Abrams
Cell Death and Differentiation. 2023-05-01 - 6 citationsGlobal DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases.Haocheng Yu, Stephanie Tuminello, Naomi Alpert, Maaike van Gerwen, Seungyeul Yoo
Carcinogenesis. 2022-06-27 - 8 citationsPatient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs.Georgios Asimomitis, André G Deslauriers, Andriana G Kotini, Elsa Bernard, Davide Esposito
Blood Advances. 2022-05-24
Grant Support
- Training Program In Cancer BiologyNational Cancer Institute2010–2011
- P53 - Regulators And EffectorsNational Cancer Institute2010–2011
- Effectors Of P53 Pro-Survival And Pro-Apoptotic Signaling PathwaysNational Cancer Institute2010–2011
- Administrative CoreNational Cancer Institute2010–2011
- WNT Receptor Signaling And CancerNational Cancer Institute2005–2009
- Effectors Of P53 Pro-Survival &Pro-Apoptotic SignalingNational Cancer Institute2005–2009
- Training Program In Cancer BiologyNational Cancer Institute2001–2009
- P53 - Regulators And EffectorsNational Cancer Institute2000–2009
- Cellular Senescence In Aging And CancerNational Cancer Institute1999–2008
- Postdoctoral Training Program In Cancer BiologyNational Cancer Institute2005–2006
- Cancer Resource--Pathology, Registry And BiorepositoriesNational Cancer Institute2002–2006
- Administrative CoreNational Cancer Institute2005
- Cloning And Analysis Of WNT Receptors In Breast CancerNational Cancer Institute1997–2004
- MAPK In P53 Induced Growth Arrest/SenescenceNational Cancer Institute2000–2002
- Training Program In Cancer TherapyNational Cancer Institute1999–2000
- Targeting Hereditary Breast Cancers Through Elucidation Of BRCA1/2 Gene FunctionsNational Cancer Institute1998–1999
- Ras-Related Oncogenes In Human TumorsNational Cancer Institute1997–1999
- ERBB And Ras-Like Oncogene Interaction In Human Breast CancerNational Cancer Institute1996–1997
- Ras-Related Oncogenes In Human TumorsNational Cancer Institute1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: